Ophthalmology Drugs
311 FDA-approved drugs
TheraRadar tracks 311 FDA-approved ophthalmology drugs from 92 companies across 20 drug classes, led by Novartis, with 269 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Ophthalmology.
Ophthalmology Approvals by Year
'15
7
'16
6
'17
5
'18
5
'19
7
'20
5
'21
5
'22
12
'23
5
'24
7
'25
1
'26
Recent Ophthalmology Drug Approvals
YUVEZZI
BRIMONIDINE TARTRATE
presbyopia in adults...
2026-01-28
VISUS
NUFYMCO
RANIBIZUMAB-LEYK
patients with: NUFYMCO, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the ...
2025-12-18
FORMYCON AG
VEGFVEGF-A
LOTEPREDNOL ETABONATE AND TOBRAMYCIN
LOTEPREDNOL ETABONATE
ster...
2025-12-10
ALEMBIC
ZOLYMBUS
BIMATOPROST
the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular ...
2025-09-09
THEA PHARMA
VIZZ
ACECLIDINE HYDROCHLORIDE
presbyopia in adults...
2025-07-31
LENZ THERAP
TRYPTYR
ACOLTREMON
the signs and symptoms of dry eye disease...
2025-05-28
Novartis
LATANOPROSTENE BUNOD
LATANOPROSTENE BUNOD
the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertens...
2025-04-29
GLAND
encelto
revakinagene taroretcel-lwey
adults with idiopathic macular telangiectasia type 2 (MacTel)...
2025-03-04
Neurotech Pharmaceuticals Inc.
ENZEEVU
AFLIBERCEPT-ABZV
2024-08-09
Novartis
YESAFILI
AFLIBERCEPT-JBVF
2024-05-20
BIOCON BIOLOGICS INC
OPUVIZ
AFLIBERCEPT-YSZY
2024-05-20
SAMSUNG BIOEPIS CO LTD
LUMIFY PRESERVATIVE FREE
BRIMONIDINE TARTRATE
2024-04-19
BAUSCH AND LOMB INC
FLUOROMETHOLONE
FLUOROMETHOLONE
corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior ...
2024-01-09
AMNEAL
IDOSE TR
TRAVOPROST
the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hyp...
2023-12-13
GLAUKOS
QLOSI
PILOCARPINE HYDROCHLORIDE
presbyopia in adults...
2023-10-17
ORASIS PHARMS
FLUORESCEIN SODIUM
FLUORESCEIN SODIUM
INDICATIONS For testing tear film stability by determining the fluorescein break-up time (FBUT)...
2023-09-25
NEXUS
RYZUMVI
PHENTOLAMINE MESYLATE
pharmacologically-induced mydriasis produced by adrenergic agonists (e...
2023-09-25
FAMYGEN LIFE SCI
LIFITEGRAST
LIFITEGRAST
2023-08-04
Sun Pharma
IZERVAY
AVACINCAPTAD PEGOL SODIUM
geographic atrophy (GA) secondary to age-related macular degeneration (AMD)...
2023-08-04
ASTELLAS
XDEMVY
LOTILANER
Demodex blepharitis...
2023-07-24
TARSUS
Showing the 20 most recent of 311 ophthalmology drugs. View all 311 →
Top Ophthalmology Companies
Ophthalmology Active Trials by Indication
269 active trials — the forward pipeline, not just approvals.
All competitive landscapes →Ophthalmology Drug Classes
Prostaglandin Analog 13
Corticosteroid 13
Calcineurin Inhibitor Immunosuppressant 5
Vascular Endothelial Growth Factor Inhibitor 4
Aminoglycoside Antibacterial 3
Carbonic Anhydrase Inhibitor 3
Quinolone Antimicrobial 3
Anticholinergic 2
Ectoparasiticide 1
Semifluorinated Alkane 1
Ophthalmology at a Glance
- Total Drugs
- 311
- Companies
- 92
- Drug Classes
- 20
- Active Trials
- 269
- Latest Approval
- 2026-01-28